Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 174   

Articles published

GSK 1,415.50 +3.50 (0.25%)
price chart
GlaxoSmithKline plc Shares Up After Earnings
GlaxoSmithKline plc (ADR) (NYSE:GSK) (LON:GSK) released the earnings results from its most recently completed quarter this morning, posting core earnings of 27.9 pence per share, excluding divestments.
2 Numbers That Could Make GlaxoSmithKline plc A Spectacular Buy
The business has seen sales in China collapse. And concern about the long-term effect that the corruption case will have on future revenue growth has weighed heavily on GlaxoSmithKline for many months now. So news last month that the case had been ...
Related articles »  
GlaxoSmithKline plc Jumps After Beating City Expectations
GlaxoSmithKline Specifically, the company reported third-quarter profit of �1.89bn, or 27.9p per share. Analysts were expecting earnings of 24.
GlaxoSmithKline Unveils Cost-Saving Plan, Considers IPO of HIV Business  Wall Street Journal
GlaxoSmithKline Shares Jump On Upbeat Earnings News, Cost-Cutting Plans  International Business Times
Related articles »  
GlaxoSmithKline plc Is Becoming More Attractive By The Day
GlaxoSmithKline plc's (LSE: GSK) share price is falling again today, which is great news, as at these prices the company is a steal.
Related articles »  
This May Be Your Last Chance To Buy Diageo plc, GlaxoSmithKline plc And ...
There's no denying that Diageo (LSE: DGE) has underperformed this year. Concerns about the company's growth have spooked investors and sales within China have been hit hard by the government's anti-extravagance measures.
Related articles »  
What Management Would Prefer You Didn't Know About GlaxoSmithKline plc
GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has unfortunately gone one step too far on a number of occasions. The actions of its representatives in China have been put under the spotlight, and now more allegations are emerging from the Middle East.
Why Have GlaxoSmithKline plc And AstraZeneca plc Followed The FTSE 100 ...
Investors tend to turn to big blue-chip dividend payers at times of market volatility, and in times past the steady earnings of pharma giants GlaxoSmithKline (LSE: GSK) and AstraZeneca (LSE: AZN) have been a particular source of comfort when the market ...
Morning Buzz: GlaxoSmithKline plc (ADR) (NYSE:GSK), Sunedison Inc (NYSE ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) reported Q3 earnings in which sales fell 10% but EPS exceeded estimates, and announced a cost savings plan, as revenues from its flagship respiratory drug Advair continued an extended decline.
Related articles »  
Beat The FTSE 100 With SABMiller plc, GlaxoSmithKline plc And British ...
With the FTSE 100 having fallen by over 8% during the last month, beating the returns on the index has become a priority for a number of UK investors.
Related articles »  
GlaxoSmithKline PLC vs AstraZeneca PLC: Which Is The Better Dividend Play?
AstraZeneca So, what is the future of pharma? With the patents of so many blockbuster drugs expiring, are pharmaceutical companies destined to decline?
What Happens If Pfizer Inc. Doesn't Come Back For AstraZeneca plc?  The Motley Fool UK
Related articles »